Please note Abbeycare no longer offer Naltrexone treatment.

Naltrexone is a ‘blocker’ solution for heroin or opiate users who need the extra support during recovery, of an antagonist drug.

This acts as a deterrent, such that, if an individual using Naltrexone relapses into opiate use, they do not experience any of the ‘highs’ or feelings of euphoria normally associated with such drugs.

Instead, they experience no feelings at all, and hence will lose the positive association paired with opiate use over time, thus discouraging relapse, and helping maintain positive recovery.

Antagonist drugs such as Naltrexone operate by occupying and blocking opiate receptor sites in the brain, meaning that any new opiates in the system cannot populate these sites and trigger the associated chemical pathways and associated feelings.

Naturally, chemical solutions such as Naltrexone aren’t intended as a solution to the cause of the addiction, merely a deterrent to further use, and encouragement on the bigger journey of recovery.

Naltrexone is normally available in both oral tablet and implant form. The Naltrexone implant itself is normally fitted in the lower abdomen, under local anaesthetic, and lasts for a period of 12 weeks. Longer durations are sometimes obtainable dependent on current regulations and availability.

However, prior to Naltrexone use, the individual must undergo a full supervised detox from opiate use t avoid any abreactions and ensure safe and comfortable use of Naltrexone.

Currently, Abbeycare are the only UK clinic to offer both opiate detoxification and Naltrexone under one roof, in the same residential clinic.

To enquire about Naltrexone or opiate detox, or arrange admission, call Abbeycare direct on 01603 513 091.

About the author

Laura Morris

Laura Morris is an experienced clinical practitioner and CQC Registered Manager with over twenty years experience, over ten of which have been as an Independent Nurse Prescriber.

She has held a number of senior leadership roles in the substance use and mental health sector in the NHS, the prison service and in leading social enterprises in the field.